Brandon E Boggs, MD
Family Practice · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 26 years
- R Franklin University of Med & Sci/Chicago Medical School, 2000
Offices
1 location
Looking this up.
Hospitals listed: Mercy Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Boggs’s office at (209) 233-9038 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A77822 · Current
Licensed to practise in California · since 2002 · expires 2028-02-29 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Medicaid work
$12,939 in 2021
Medicaid paid $12,939 for 154 billed services this clinician did in 2021, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 45 | $5,298 |
| Short return visit (20+ min) | 52 | $3,817 |
| Return visit (30+ min) | 45 | $3,807 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 12 | $18 |
| 2021 | 154 | 4 | 38 | $12,939 |
| 2019 | 204 | 5 | 44 | $5,007 |
See the largest Medicaid services in earlier years
2019
| Return visit (30+ min) | 84 | $3,209 |
| Short return visit (20+ min) | 63 | $1,492 |
| Screening test, pure tone, air only | 21 | $217 |
| Bilateral quantitative screening test of visual acuity | 17 | $58 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 19 | $31 |
Drugs they prescribed that Part D paid
$89,894
Pharmacies billed $89,894 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (43 of 1,356) in 2024. At or below the middle of the specialty; the typical emergency medicine clinician is at 12%.
1,201 generic and fewer than 11 brand-name prescriptions · $89,894 in drug cost · 74 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 13 | $8,437 | $649 |
| Spiriva Respimat | 11 | $5,565 | $506 |
| Lantus Solostar | 18 | $4,790 | $266 |
| Atorvastatin | 101 | $1,029 | $10 |
| Levothyroxine | 41 | $736 | $18 |
See all 39 drugs
| Farxiga | 13 | $8,437 | $649 |
| Spiriva Respimat | 11 | $5,565 | $506 |
| Lantus Solostar | 18 | $4,790 | $266 |
| Atorvastatin | 101 | $1,029 | $10 |
| Levothyroxine | 41 | $736 | $18 |
| Gabapentin | 24 | $534 | $22 |
| Escitalopram | 48 | $526 | $11 |
| Losartan | 47 | $507 | $11 |
| Amlodipine Besylate | 33 | $496 | $15 |
| Butalb-Acetaminoph-Caff-Codein | 11 | $486 | $44 |
| Pantoprazole | 29 | $461 | $16 |
| Tamsulosin | 21 | $415 | $20 |
| Zolpidem | 44 | $400 | $9 |
| Omeprazole | 27 | $378 | $14 |
| Fluticasone Propionate | 15 | $340 | $23 |
| Metoprolol | 28 | $330 | $12 |
| Sertraline | 20 | $315 | $16 |
| Pravastatin | 18 | $313 | $17 |
| Metformin | 38 | $309 | $8 |
| Valacyclovir | 12 | $245 | $20 |
| Propranolol | 12 | $234 | $20 |
| Rosuvastatin | 20 | $215 | $11 |
| Lisinopril | 38 | $205 | $5 |
| Metoprolol | 24 | $187 | $8 |
| Topiramate | 18 | $158 | $9 |
| Tramadol | 24 | $158 | $7 |
| Meloxicam | 17 | $145 | $9 |
| Amiodarone | 11 | $144 | $13 |
| Azithromycin | 30 | $143 | $5 |
| Simvastatin | 12 | $124 | $10 |
| Hydrochlorothiazide | 19 | $117 | $6 |
| Finasteride | 11 | $108 | $10 |
| Ciprofloxacin | 15 | $91 | $6 |
| Montelukast | 14 | $76 | $5 |
| Repaglinide | 11 | $68 | $6 |
| Cephalexin | 11 | $66 | $6 |
| Lorazepam | 11 | $60 | $5 |
| Citalopram Hbr | 11 | $33 | $3 |
| Paxlovid | 16 | $0 | $0 |
Year by year
| 2024 | 1,356 | 100 | 3% (43) | None | $89,894 |
| 2023 | 1,165 | 85 | 4% (43) | 9% | $93,571 |
| 2022 | 759 | 59 | 6% (45) | 6% | $28,633 |
| 2021 | 407 | 44 | 9% (35) | 6% | $7,834 |
| 2020 | 203 | 22 | 6% (12) | None | $3,746 |
| 2019 | 138 | 25 | None | 13% | $1,462 |
| 2018 | 75 | None | None | None | $4,735 |
| 2017 | 85 | 12 | 0% (0) | None | $5,918 |
| 2016 | 76 | 28 | None | None | $2,540 |
| 2015 | 75 | 42 | None | None | $1,788 |
| 2014 | 50 | 29 | None | 30% | $3,036 |
| 2013 | 45 | 18 | None | 24% | $1,588 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Atorvastatin | 92 | $1,269 | $14 |
| Zolpidem | 50 | $644 | $13 |
| Amlodipine Besylate | 40 | $636 | $16 |
| Butalb-Acetaminoph-Caff-Codein | 13 | $600 | $46 |
| Omeprazole | 22 | $556 | $25 |
| Losartan | 42 | $440 | $10 |
| Tamsulosin | 22 | $407 | $18 |
| Levothyroxine | 25 | $380 | $15 |
| Metformin | 28 | $377 | $13 |
| Metoprolol | 21 | $366 | $17 |
| Cephalexin | 19 | $356 | $19 |
| Pravastatin | 22 | $353 | $16 |
| Rosuvastatin | 20 | $329 | $16 |
| Pantoprazole | 18 | $299 | $17 |
| Propranolol | 15 | $291 | $19 |
| Valacyclovir | 11 | $283 | $26 |
| Sertraline | 29 | $271 | $9 |
| Escitalopram | 26 | $257 | $10 |
| Lisinopril | 25 | $250 | $10 |
| Montelukast | 12 | $194 | $16 |
| Tramadol | 24 | $184 | $8 |
| Metoprolol | 20 | $156 | $8 |
| Hydrochlorothiazide | 20 | $156 | $8 |
| Enalapril Maleate | 11 | $140 | $13 |
| Paxlovid (Eua) | 12 | $128 | $11 |
| Simvastatin | 11 | $114 | $10 |
| Donepezil | 11 | $107 | $10 |
| Topiramate | 17 | $103 | $6 |
| Alprazolam | 18 | $103 | $6 |
| Triamcinolone Acetonide | 11 | $76 | $7 |
| Azithromycin | 12 | $65 | $5 |
2022: 22 drugs
| Rasagiline Mesylate | 13 | $1,492 | $115 |
| Gabapentin | 18 | $672 | $37 |
| Atorvastatin | 52 | $606 | $12 |
| Asa-Butalb-Caffeine-Codeine | 13 | $401 | $31 |
| Pantoprazole | 20 | $385 | $19 |
| Amlodipine Besylate | 28 | $371 | $13 |
| Zolpidem | 49 | $331 | $7 |
| Omeprazole | 17 | $313 | $18 |
| Losartan | 21 | $279 | $13 |
| Propranolol | 11 | $265 | $24 |
| Tamsulosin | 11 | $249 | $23 |
| Levothyroxine | 16 | $212 | $13 |
| Paxlovid (Eua) | 19 | $198 | $10 |
| Simvastatin | 11 | $172 | $16 |
| Tramadol | 26 | $167 | $6 |
| Ciprofloxacin | 14 | $146 | $10 |
| Azithromycin | 19 | $113 | $6 |
| Escitalopram | 20 | $105 | $5 |
| Alprazolam | 12 | $66 | $5 |
| Losartan-Hydrochlorothiazide | 13 | $66 | $5 |
| Sertraline | 25 | $49 | $2 |
| Hydrochlorothiazide | 27 | $41 | $2 |
2021: 11 drugs
| Omeprazole | 21 | $288 | $14 |
| Atorvastatin | 17 | $242 | $14 |
| Atenolol | 11 | $219 | $20 |
| Tramadol | 22 | $213 | $10 |
| Pantoprazole | 13 | $212 | $16 |
| Levothyroxine | 12 | $207 | $17 |
| Amlodipine Besylate | 20 | $188 | $9 |
| Montelukast | 12 | $152 | $13 |
| Zolpidem | 15 | $132 | $9 |
| Escitalopram | 18 | $65 | $4 |
| Hydrochlorothiazide | 15 | $47 | $3 |
2020: 4 drugs
| Tramadol | 12 | $87 | $7 |
| Meloxicam | 11 | $79 | $7 |
| Zolpidem | 11 | $57 | $5 |
| Hydrochlorothiazide | 14 | $32 | $2 |
2019: 4 drugs
| Atorvastatin | 11 | $264 | $24 |
| Allopurinol | 13 | $90 | $7 |
| Amlodipine Besylate | 12 | $51 | $4 |
| Metoprolol | 12 | $28 | $2 |
2018: 2 drugs
| Allopurinol | 11 | $55 | $5 |
| Metoprolol | 11 | $55 | $5 |
2017: 1 drug
| Lisinopril | 15 | $55 | $4 |
2016: 1 drug
| Metoprolol | 12 | $91 | $8 |
2014: 1 drug
| Celebrex | 12 | $2,490 | $207 |
2013: 1 drug
| Atorvastatin | 11 | $406 | $37 |
Professional record
- NPI
- 1386655520
- Licence
- CA A77822California A77822: Current · expires 2028-02-29
- Trained
- R Franklin University of Med & Sci/Chicago Medical School, 2000 · 26 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A778220
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 3178 Collins Dr, Ste B, Merced, CA, 95348
- NPI first listed
- 2006-08-11
- NPI last updated
- 2026-02-10
- NPI record certified
- 2026-02-10
This is when the NPI record was last certified, not a medical board exam.